{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:58:40Z","timestamp":1792133920274,"version":"4.4.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"7","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.autrev.2013.02.001","type":"journal-article","created":{"date-parts":[[2013,2,24]],"date-time":"2013-02-24T14:15:16Z","timestamp":1361715316000},"page":"784-791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Management of immune cytopenias in patients with systemic lupus erythematosus \u2014 Old and new"],"prefix":"10.1016","volume":"12","author":[{"given":"Kam","family":"Newman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Bagher","family":"Owlia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihab","family":"El-Hemaidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojtaba","family":"Akhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2013.02.001_bb0005","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1093\/rheumatology\/keq269","article-title":"The management of peripheral blood cytopenias in systemic lupus erythematosus","volume":"49","author":"Hepburn","year":"2010","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2013.02.001_bb0010","series-title":"Lupus: symptoms, treatment and potential complications","first-page":"129","article-title":"Hematologic manifestations of systemic lupus erythematosus","author":"Newman","year":"2012"},{"key":"10.1016\/j.autrev.2013.02.001_bb0015","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.autrev.2012.06.002","article-title":"Autoimmune diseases in the intensive care unit. An update","volume":"12","author":"Quintero","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0020","series-title":"The clinical management of systemic lupus erythematosus","article-title":"Hematologic manifestation","author":"Shoenfeld","year":"1996"},{"key":"10.1016\/j.autrev.2013.02.001_bb0025","first-page":"605","article-title":"Prevalence and significance of hematological abnormalities in patients with systemic lupus erythematosus","volume":"80","author":"Nossent","year":"1991","journal-title":"Q J Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0268-960X(93)90006-P","article-title":"Haematological manifestations of systemic lupus erythematosus","volume":"7","author":"Keeling","year":"1993","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0035","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1177\/0961203308090990","article-title":"Haemolytic anaemia in a multi-ethnic cohort of lupus patients: a clinical and serological perspective","volume":"17","author":"Jeffries","year":"2008","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.autrev.2013.02.001_bb0040","doi-asserted-by":"crossref","first-page":"A350","DOI":"10.1016\/j.autrev.2009.11.005","article-title":"Geoepidemiology of autoimmune hemolytic anemia","volume":"9","author":"Lambert","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0045","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1191\/0961203306lu2292oa","article-title":"Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases","volume":"15","author":"Gomard-Mennesson","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.seminhematol.2005.04.003","article-title":"Treatment of autoimmune hemolytic anemia","volume":"42","author":"King","year":"2005","journal-title":"Semin Hematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0055","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/096120301676669495","article-title":"Azathioprine therapy for patients with systemic lupus erythematosus","volume":"10","author":"Abu-Shakra","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0060","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/0002-9343(66)90086-6","article-title":"Azathioprine therapy of \u201cautoimmune\u201d diseases","volume":"41","author":"Corley","year":"1966","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.autrev.2013.02.001_bb0065","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2141.1993.tb08293.x","article-title":"Danazol in autoimmune hemolytic anemia","volume":"83","author":"Pignon","year":"1993","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0070","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.semarthrit.2010.03.005","article-title":"Danazol in the treatment of systemic lupus erythematosus: a qualitative systematic review","volume":"40","author":"Letchumanan","year":"2011","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0075","first-page":"280","article-title":"Danazol therapy in autoimmune hemolytic anemia associated with systemic lupus erythematosus","volume":"18","author":"Chan","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0080","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1191\/096120399678841007","article-title":"A study of 20 SLE patients with intravenous immunoglobulin-clinical and serologic response","volume":"8","author":"Levy","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0085","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1385\/CRIAI:29:3:219","article-title":"Intravenous immunoglobulin therapy and systemic lupus erythematosus","volume":"29","author":"Zandman-Goddard","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2013.02.001_bb0500","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1016\/j.intimp.2011.07.024","article-title":"Hematologic toxicities associated with intravenous immunoglobulin therapy","volume":"11","author":"Baxley","year":"2011","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"10.1016\/j.autrev.2013.02.001_bb0090","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/art.10541","article-title":"An open study of B lymphocyte depletion in systemic lupus erythematosus","volume":"46","author":"Leandro","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2013.02.001_bb0095","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07054.x","article-title":"Rituximab in the treatment of autoimmune haematological disorders","volume":"141","author":"Garvey","year":"2008","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.autrev.2013.02.001_bb0100","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1002\/art.20592","article-title":"Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus","volume":"50","author":"Anolik","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2013.02.001_bb0105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/0961203310395802","article-title":"Assessment of flares in lupus patients enrolled in a phase II\/III study of rituximab (EXPLORER)","volume":"20","author":"Merrill","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0495","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/ard.2004.029694","article-title":"Tolerance and short term efficacy of rituximab in 43 patients with systemic autoimmune diseases","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2013.02.001_bb0110","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.autrev.2010.07.013","article-title":"Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: two sides of the same coin","volume":"9","author":"Conti","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0115","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/s10165-007-0565-z","article-title":"A multicenter phase I\/II trial of refractory systemic lupus erythematosus","volume":"17","author":"Tanaka","year":"2007","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0120","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/rheumatology\/kei080","article-title":"B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients","volume":"44","author":"Leandro","year":"2005","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.autrev.2013.02.001_bb0125","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1002\/art.22046","article-title":"Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis. Remission, relapse, and re-treatment","volume":"54","author":"Smith","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0130","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/0961203308094653","article-title":"Effects of rituximab on resistant SLE disease including lung involvement","volume":"18","author":"Reynolds","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0140","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2141.2002.03278.x","article-title":"Anti-CD20 monoclonal antibody (rituximab) for life-threatening autoimmune haemolytic anaemia in a patient with systemic lupus erythematosus","volume":"116","author":"Perrotta","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00277-010-0997-y","article-title":"Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia","volume":"89","author":"Penalver","year":"2010","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.autrev.2013.02.001_bb0150","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1365-2796.2009.02126.x","article-title":"Rituximab in auto-immune haemolytic anaemia and immune thrombocytopenic purpura: a Belgian retrospective multicentric study","volume":"266","author":"Dierickx","year":"2009","journal-title":"J Intern Med"},{"issue":"26","key":"10.1016\/j.autrev.2013.02.001_bb0155","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1056\/NEJM200306263482619","article-title":"Interstitial pneumonitis related to rituximab therapy","volume":"348","author":"Burton","year":"2003","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.autrev.2013.02.001_bb0160","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1056\/NEJM200306263482620","article-title":"Neutropenia in patients treated with rituximab","volume":"348","author":"Voog","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0165","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1191\/0961203303lu419cr","article-title":"Mycophenolate mofetil as a treatment for autoimmune haemolytic anaemia in patients with systemic lupus erythematosus and antiphospholipid syndrome","volume":"12","author":"Alba","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0170","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1191\/0961203305lu2163cr","article-title":"Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus","volume":"14","author":"Mak","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0175","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1080\/03009740701607042","article-title":"Mycophenolate mofetil for non-renal manifestations of systemic lupus erythematosus: a systemic review","volume":"36","author":"Mok","year":"2007","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1046\/j.1365-2141.2002.03430.x","article-title":"Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenic purpura","volume":"117","author":"Howard","year":"2002","journal-title":"Br J Haematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0185","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1182\/blood-2002-01-0087","article-title":"High-dose cyclophosphamide for refractory autoimmune hemolytic anemia","volume":"100","author":"Moyo","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2013.02.001_bb0190","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00062752-200311000-00006","article-title":"Red blood cell transfusion in autoimmune hemolytic anemia","volume":"10","author":"Buetens","year":"2003","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0195","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/ard.59.3.217","article-title":"Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin","volume":"59","author":"Voulgarelis","year":"2000","journal-title":"Ann Rheumatol Dis"},{"issue":"5","key":"10.1016\/j.autrev.2013.02.001_bb0200","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/art.1780310518","article-title":"High-dose intravenous cyclophosphamide treatment of systemic lupus erythematosus-associated aplastic anemia","volume":"31","author":"Winkler","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0205","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00296-003-0318-z","article-title":"Aplastic anemia complicating systemic lupus erythematosus: successful management with cyclosporine","volume":"24","author":"Singh","year":"2004","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2013.02.001_bb0210","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/archinte.1984.00350190172030","article-title":"Serum inhibitor in systemic lupus erythematosus associated with aplastic anemia","volume":"144","author":"Brooks","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0215","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/0002-9343(79)91097-0","article-title":"Serum inhibitors of hematopoiesis in a patient with aplastic anemia and systemic lupus erythematosus. Recovery after exchange plasmapheresis","volume":"66","author":"Fitchen","year":"1979","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1053\/sarh.2002.30440","article-title":"Pure red cell aplasia and lupus","volume":"31","author":"Habib","year":"2002","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0225","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1365-2249.1995.tb03726.x","article-title":"Suppression of haematopoiesis by IgG autoantibodies from patients with systemic lupus erythematosis (SLE)","volume":"100","author":"Liu","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0230","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/ajh.21241","article-title":"Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies","volume":"83","author":"Hara","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0235","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1001\/archinte.1984.00350190172030","article-title":"Serum inhibitors in systemic lupus erythematosus associated with aplastic anemia","volume":"144","author":"Brooks","year":"1984","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0240","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/rheumatology\/30.4.301","article-title":"Aplastic anaemia in systemic lupus erythematosus: a cellular immune mechanism?","volume":"30","author":"Roffe","year":"1991","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0245","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00787-2","article-title":"Pure red cell aplasia as the first manifestation of systemic lupus erythematosus","volume":"11","author":"Jimeno Sainz","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0250","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s00296-004-0521-6","article-title":"Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with oral danazol and steroid","volume":"25","author":"Chan","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2013.02.001_bb0255","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000204509","article-title":"Pure red cell aplasia associated with systemic lupus erythematosus: remission after a single course of intravenous immunoglobulin","volume":"89","author":"Ilan","year":"1993","journal-title":"Acta Haematol"},{"issue":"5","key":"10.1016\/j.autrev.2013.02.001_bb0260","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.autrev.2004.10.004","article-title":"Intravenous immunoglobulins in autoimmune- or parvovirus B19-mediated pure red cell aplasia","volume":"4","author":"Mouthon","year":"2005","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0265","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/rheumatology\/39.10.1155","article-title":"Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporine A","volume":"39","author":"Duarte-Salazar","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2013.02.001_bb0270","first-page":"759","article-title":"Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporine A","volume":"21","author":"Atzeni","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0275","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/ajh.20237","article-title":"T-cell-mediated pure red cell aplasia in systemic lupus erythematosus: response to cyclosporine A and mycophenolate mofetil","volume":"78","author":"Arcasoy","year":"2005","journal-title":"Am J Hematol"},{"issue":"4","key":"10.1016\/j.autrev.2013.02.001_bb0280","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/ar1208","article-title":"Lymphopenia and autoimmune diseases","volume":"6","author":"Schulze-Koops","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2013.02.001_bb0285","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/kel016","article-title":"Moderate and severe neutropenia in patients with systemic lupus erythematosus","volume":"45","author":"Martinez-Banos","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2013.02.001_bb0290","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.autrev.2009.03.006","article-title":"Autoimmune neutropenia in adults","volume":"9","author":"Akhtari","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0295","first-page":"175","article-title":"Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus","volume":"3","author":"Utsinger","year":"1976","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0300","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.autrev.2011.01.006","article-title":"Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus","volume":"10","author":"Newman","year":"2011","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2013.02.001_bb0305","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/35.7.669","article-title":"Cyclosporine A in the treatment of systemic lupus erythematosus: results of an open clinical study","volume":"35","author":"Manger","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0310","first-page":"2153","article-title":"Recombinant human granulocyte colony stimulating factor in patients with systemic lupus erythematosus associated neutropenia and refractory infections","volume":"24","author":"Euler","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0315","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0049-0172(99)80040-7","article-title":"Treatment of severe neutropenia due to Felty's syndrome or systemic lupus erythematosus with granulocyte colony-stimulating factor","volume":"29","author":"Hellmich","year":"1999","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0320","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/rheumatology\/kel010","article-title":"Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus","volume":"45","author":"Kuwana","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2013.02.001_bb0325","first-page":"311","article-title":"Pulse corticosteroid therapy for refractory thrombocytopenia in systemic lupus erythematosus","volume":"9","author":"Lurie","year":"1982","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2013.02.001_bb0330","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/art.1780330825","article-title":"Intravenous immunoglobulin therapy in systemic lupus erythematosus-associated thrombocytopenia","volume":"33","author":"Maier","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0335","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1136\/ard.51.10.1149","article-title":"Treatment of severe thrombocytopenia in systemic lupus erythematosus with intravenous gamma globulin","volume":"51","author":"ter Borg","year":"1992","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.02.001_bb0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3109\/s10165-006-0482-6","article-title":"A case of systemic lupus erythematosus expressing intractable thrombocytopenia remedied effectively by intermittent and continuous administration of a small amount of immune globulin","volume":"16","author":"Maeshima","year":"2006","journal-title":"Mod Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2013.02.001_bb0345","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/03009749409103065","article-title":"Treatment of hemolytic anemia and severe thrombocytopenia with high-dose methyl prednisolone and intravenous immunoglobulins in SLE","volume":"23","author":"Roldan","year":"1994","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0350","doi-asserted-by":"crossref","first-page":"703","DOI":"10.7326\/0003-4819-108-5-703","article-title":"Danazol for the treatment of refractory autoimmune thrombocytopenia in systemic lupus erythematosus","volume":"108","author":"West","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0355","first-page":"1867","article-title":"Danazol for systemic lupus erythematosus with refractory autoimmune thrombocytopenia or Evans' syndrome","volume":"22","author":"Cervera","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0360","first-page":"75","article-title":"Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus: 59 cases","volume":"29","author":"Arnal","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0365","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1191\/0961203303lu337oa","article-title":"Long-term effectiveness of danazol corticosteroids and cytotoxic drugs in the treatment of hematologic manifestations of systemic lupus erythematosus","volume":"12","author":"Avina-Zubieta","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0370","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1191\/096120301671376017","article-title":"Cyclophosphamide for the treatment of systemic lupus erythematosus","volume":"10","author":"Akada","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0375","doi-asserted-by":"crossref","first-page":"674","DOI":"10.7326\/0003-4819-112-9-674","article-title":"Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus","volume":"112","author":"Boumpas","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0380","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1191\/0961203303lu417cr","article-title":"Refractory immune thrombocytopenia in systemic lupus erythematosus: response to mycophenolate mofetil","volume":"12","author":"Vasoo","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0385","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1191\/096120398678919660","article-title":"Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus","volume":"7","author":"Sugiyama","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0390","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1191\/0961203306lu2266oa","article-title":"Efficacy of cyclosporine-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus","volume":"15","author":"Quartuccio","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0395","first-page":"826","article-title":"Long-term clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus","volume":"35","author":"Lindholm","year":"2008","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2013.02.001_bb0400","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00277-011-1283-3","article-title":"Efficacy of rituximab in immune thrombocytopenic purpura: a retrospective survey","volume":"91","author":"Brah","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0609.1973.tb00035.x","article-title":"Evaluation of azathioprine in autoimmune thrombocytopenia and lupus erythematosus","volume":"10","author":"Goebel","year":"1973","journal-title":"Scand J Haematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0410","first-page":"44","article-title":"Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11","author":"Feinglass","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2013.02.001_bb0415","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1160\/TH08-12-0825","article-title":"Heterogeneous pathogenic processes of thrombotic microangiopathies in patients with connective tissue diseases","volume":"102","author":"Matsuyama","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.autrev.2013.02.001_bb0420","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOH.0b013e328309ec62","article-title":"Current management of thrombotic thrombocytopenic purpura","volume":"15","author":"Kremer Hovinga","year":"2008","journal-title":"Curr Opin Hematol"},{"issue":"9","key":"10.1016\/j.autrev.2013.02.001_bb0425","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/SMJ.0b013e3181809ebd","article-title":"Rituximab therapy for refractory thrombotic thrombocytopenic purpura and autoimmune-mediated thrombocytopenia in systemic lupus erythematosus","volume":"101","author":"Hundae","year":"2008","journal-title":"South Med J"},{"key":"10.1016\/j.autrev.2013.02.001_bb0430","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/0961203307083479","article-title":"Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus","volume":"17","author":"Limal","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0435","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2169\/internalmedicine.46.6192","article-title":"Successful treatment of refractory thrombotic thrombocytopenic purpura with cyclosporine and corticosteroids in a patient with systemic lupus erythematosus and antibodies to ADAMTS13","volume":"46","author":"Enami","year":"2007","journal-title":"Intern Med"},{"issue":"5","key":"10.1016\/j.autrev.2013.02.001_bb0440","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1080\/030097401753180417","article-title":"Thrombotic thrombocytopenic purpura and systemic lupus erythematosus","volume":"30","author":"Vaidya","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0445","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.45.4.319","article-title":"Thrombotic thrombocytopenic purpura and systemic lupus erythematosus","volume":"45","author":"Fox","year":"1986","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2013.02.001_bb0450","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1600-0609.2005.00526.x","article-title":"Acquired thrombotic thrombocytopenic purpura as the presenting symptom of systemic lupus erythematosus. Successful treatment with plasma exchange and immunosuppression-report of two cases","volume":"75","author":"Starck","year":"2005","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1191\/0961203302lu224oa","article-title":"Thrombotic thrombocytopenic purpura in systemic lupus erythematosus: disease activity and the use of cytotoxic drugs","volume":"11","author":"Vasoo","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2013.02.001_bb0460","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s002770050516","article-title":"Use of cyclophosphamide in the treatment of thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: report of two cases","volume":"78","author":"Perez-Sanchez","year":"1999","journal-title":"Ann Hematol"},{"key":"10.1016\/j.autrev.2013.02.001_bb0465","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/archinte.1979.03630440039014","article-title":"Splenectomy for hemocytopenia in systemic lupus erythematosus. A controlled appraisal","volume":"139","author":"Rivero","year":"1979","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0470","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/0003-4819-102-3-325","article-title":"Splenectomy does not cure the thrombocytopenia of systemic lupus erythematosus","volume":"102","author":"Hall","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2013.02.001_bb0475","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0049-0172(98)80024-3","article-title":"Autoimmune thrombocytopenia in primary antiphospholipid syndrome and systemic lupus erythematosus: the response to splenectomy","volume":"28","author":"Hakim","year":"1998","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2013.02.001_bb0480","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1097\/01.sla.0000133182.92780.9c","article-title":"Outcome of splenectomy for thrombocytopenia associated with systemic lupus erythematosus","volume":"240","author":"You","year":"2004","journal-title":"Ann Surg"},{"issue":"3","key":"10.1016\/j.autrev.2013.02.001_bb0485","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0002-9610(88)80097-7","article-title":"Splenectomy for cytopenias associated with systemic lupus erythematosus","volume":"155","author":"Coon","year":"1988","journal-title":"Am J Surg"},{"issue":"7","key":"10.1016\/j.autrev.2013.02.001_bb0490","first-page":"366","article-title":"Splenectomy in systemic lupus erythematosus","volume":"52","author":"Gruenberg","year":"1986","journal-title":"Am Surg"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997213000256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T22:23:43Z","timestamp":1562711023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997213000256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":99,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S1568997213000256"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2013.02.001","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of immune cytopenias in patients with systemic lupus erythematosus \u2014 Old and new","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2013.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}